Bibliography

Abbot NC, Stead LF, White AR, Barnes J, Ernst E. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev. 2000(2):CD001008.

Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395-409.

Abu Hassan H, Abd Aziz N, Hassan Y, Hassan F. Does the duration of smoking cessation have an impact on hospital admission and health-related quality of life amongst COPD patients? Int J Chron Obstruct Pulmon Dis. 2014;9:493-498.

Agency for Healthcare Research and Quality. Overcoming Barriers to Shared Decision making Webinar. 2015.

Agency for Healthcare Research and Quality. The SHARE Approach. 2017; http://www.ahrq.gov/professionals/education/curriculum-tools/shareddecisionmaking/index.html.

Alberts WM, Physicians ACoC. Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd Edition). Chest. 2007;132(3 Suppl):1S-19S.

Physicians AAoF. Clinical Preventive Service Recommendation – Lung Cancer. In. Retrieved from https://www.aafp.org/patient-care/clinical-recommendations/all/lung-cancer.html. 2013.

American Academy of Family Physicians. Clinical Preventive Service Recommendation – Lung Cancer Screening. 2013; https://www.aafp.org/patient-care/clinical-recommendations/all/lung-cancer.html.

American Cancer Society. Cancer Facts & Figures 2014. In. Atlanta: American Cancer Society; 2014.

American College of Radiology. Lung-RADS Assessment Categories. 2014; https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Lung-Rads. CY 2018 OPPS Final Rule Initial Summary [press release]. 2017.

American College of Radiology. LCSR Required Data Elements. 2017; https://nrdrsupport.acr.org/support/solutions/articles/11000041252.

American Lung Association. Is lung cancer screening right for me? 2017; http://www.lung.org/assets/documents/lung-cancer/interactive-library/lung-cancer-screening-is-it.pdf.

Anderson JE, Jorenby DE, Scott WJ, Fiore MC. Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation. Chest. 2002;121(3):932-941.

Bai C, Choi CM, Chu CM, et al. Evaluation of Pulmonary Nodules: Clinical Practice Consensus Guidelines for Asia. Chest. 2016;150(4):877-893.

Baldwin DR. Development of Guidelines for the Management of Pulmonary Nodules: Toward Better Implementation. Chest. 2015;148(6):1365-1367.

Bissell P, May CR, Noyce PR. From compliance to concordance: barriers to accomplishing a re-framed model of health care interactions. Soc Sci Med. 2004;58(4):851-862.

Borondy Kitts AK, McKee AB, Regis SM, Wald C, Flacke S, McKee BJ. Smoking cessation results in a clinical lung cancer screening program. J Thorac Dis. 2016;8(Suppl 6):S481-487.

Burkholder R, Legare F, Friedberg M, Fournier A. Overcoming Barriers to Shared Decision-Making [webinar] [Internet]: Agency for Healthcare Research and Quality; 2015. Podcast. Available from: https://www.pcpcc.org/event/2015/05/ahrq-national-webinar-overcoming-barriers-shared-decision-making-webinar.

Carlson C. Medicare outlines payment rules for CT lung cancer screening. 2016.

Carter-Harris L, Davis LL, Rawl SM. Lung Cancer Screening Participation: Developing a Conceptual Model to Guide Research. Res Theory Nurs Pract. 2016;30(4):333-352.

Carter-Harris L, Gould MK. Multilevel Barriers to the Successful Implementation of Lung Cancer Screening: Why Does It Have to Be So Hard? Ann Am Thorac Soc. 2017;14(8):1261-1265.

Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med. 1997;44(5):681-692.

Department of Health and Human Services. Center for Medicare & Medicaid Services. Decision Memo for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) (CAG- 00439N). 2015; https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=274.

Department of Health and Human Services. Centers for Medicare & Medicaid Services. Eligible Professional Meaningful Use Core Measures. Measure 9 of 13. 2014; https://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/downloads/9_Record_Smoking_Status.pdf.

Department of Health and Human Services. Centers for Medicare & Medicaid Services. Pub 100-04 Medicare Claims Processing. 2015; https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/Downloads/R3374CP.pdf.

Department of Health and Human Services. Centers for Medicare & Medicaid Services. Medicare Coverage of Screening for Lung Cancer with Low Dose Computed Tomography (LDCT). MLN Matters Number: MM9246 Revised. 2017; https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/Downloads/MM9246.pdf.

Department of Health and Human Services. Centers for Medicare and Medicaid Services. CMS Credentialed Video on Lung cancer screening.

DeSantis C, Naishadham D, Jemal A. Cancer statistics for African Americans, 2013. CA Cancer J Clin. 2013;63(3):151-166.

Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e78S-e92S.

Fintelmann FJ, Bernheim A, Digumarthy SR, et al. The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program. Radiographics. 2015;35(7):1893- 1908.

Gallagher CM, Goovaerts P, Jacquez GM, Hao Y, Jemal A, Meliker JR. Racial disparities in lung cancer mortality in U.S. congressional districts, 1990-2001. Spat Spatiotemporal Epidemiol. 2009;1(1):41-47.

Gordon HS, Street RL, Sharf BF, Kelly PA, Souchek J. Racial differences in trust and lung cancer patients’ perceptions of physician communication. J Clin Oncol. 2006;24(6):904-909.

Gould MK, Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e93S-e120S.

Gould MK, Fletcher J, Iannettoni MD, et al. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3 Suppl):108S-130S.

Haskins IN, Amdur R, Vaziri K. The effect of smoking on bariatric surgical outcomes. Surg Endosc. 2014;28(11):3074-3080.

Henschke CI. International Lung Cancer Action Program: Screening Protocol. In. Retrieved from http://www.ielcap.org/sites/default/files/I-ELCAP-protocol.pdf. 2016.

Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389(10066):299-311.

International Early Lung Cancer Action Program. I-ELCAP Training Protocols https://www.ielcap.org/sites/default/files/I-ELCAP-protocol.pdf.

International Early Lung Cancer Action Program. Publications. http://www.ielcap.org/publications.

Jaklitsch MT, Jacobson FL, Austin JH, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg. 2012;144(1):33-38.

Japuntich SJ. Racial Disparities in Lung Cancer Screening: An Exploratory Investigation. In. Journal of the National Medical Association. 2017.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225-249.

Joseph-Williams N, Elwyn G, Edwards A. Knowledge is not power for patients: a systematic review and thematic synthesis of patient-reported barriers and facilitators to shared decision making. Patient Educ Couns. 2014;94(3):291-309.

Kozower BD, Larner JM, Detterbeck FC, Jones DR. Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e369S-e399S.

Leone FT, Evers-Casey S, Toll BA, Vachani A. Treatment of tobacco use in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e61S-e77S.

Lung Cancer Alliance. National Framework For Excellence in Lung Cancer Screening And Continuum of Care. https://lungcanceralliance.org/wp-content/uploads/2017/09/LCA_FrameworkBrochure_3_Color_FINAL-1.pdf.

Løkke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006;61(11):935-939.

MacMahon H, Naidich DP, Goo JM, et al. Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. Radiology. 2017;284(1):228- 243.

Mazzone P, Powell CA, Arenberg D, et al. Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest. 2015;147(2):295-303.

Mazzone P. Lung Cancer Screening Guidelines. Paper presented at American College of Chest Physicians 2017; Toronto, ON.

Mazzone PJ, Silvestri GA, Patel S, et al. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. Chest. 2018;153(4):954-985.

McKee BJ, McKee AB, Kitts AB, Regis SM, Wald C. Low-dose computed tomography screening for lung cancer in a clinical setting: essential elements of a screening program. J Thorac Imaging. 2015;30(2):115-129.

Metaxas E, Balis E, Kakavas s, Maimari M, Porfiridis I. Extended Survival After Accidental Finding of Malignant Pleural Mesothelioma Presenting as Solitary Lung Nodule [abstract]. In. Chest 2016.

Moyer VA, Force USPST. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(5):330-338.

Mulshine JL, Gierada DS, Armato SG, et al. Role of the Quantitative Imaging Biomarker Alliance in optimizing CT for the evaluation of lung cancer screen-detected nodules. J Am Coll Radiol. 2015;12(4):390-395.

National Academies of Sciences E, and Medicine,. Implementation of Lung Cancer Screening: Proceedings of a Workshop. In. Washington, DC: The National Academies Press; 2017.

National Comprehensive Cancer Network. Lung Cancer Screening. Version 1.2017. In:2017.

NLST Smoking Status Questionnaire. ACRIN SS 6654. https://www.acrin.org/Portals/0/Protocols/6654/forms/6654ss.pdf.

Patz EF, Pinsky P, Gatsonis C, et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. 2014;174(2):269-274.

Penner LA, Dovidio JF, Gonzalez R, et al. The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions. J Clin Oncol. 2016;34(24):2874-2880.

Pinsky PF, Gierada DS, Black W, et al. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med. 2015;162(7):485-491.

Rydzak CE, Armato SG, Avila RS, Mulshine JL, Yankelevitz DF, Gierada DS. Quality assurance and quantitative imaging biomarkers in low-dose CT lung cancer screening. Br J Radiol. 2017:20170401.

Sekine Y, Katsura H, Koh E, Hiroshima K, Fujisawa T. Early detection of COPD is important for lung cancer surveillance. Eur Respir J. 2012;39(5):1230-1240.

Sevick-Muraca EM, Frank RA, Giger, L. M, Mulshine JL. Moonshot Acceleration Factor: Medical Imaging. Cancer Res. 2017.

Shemesh J. Coronary artery calcification in clinical practice: what we have learned and why should it routinely be reported on chest CT? Ann Transl Med. 2016;4(8):159.

Siana JE, Rex S, Gottrup F. The effect of cigarette smoking on wound healing. Scand J Plast Reconstr Surg Hand Surg. 1989;23(3):207-209.

Soo RA, Stone ECA, Cummings KM, et al. Scientific Advances in Thoracic Oncology 2016. J Thorac Oncol. 2017;12(8):1183-1209.

Tammemägi MC, Berg CD, Riley TL, Cunningham CR, Taylor KL. Impact of lung cancer screening results on smoking cessation. J Natl Cancer Inst. 2014;106(6):dju084.

Tammemägi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med. 2013;368(8):728-736.

Tanner NT, Aggarwal J, Gould MK, et al. Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest. 2015;148(6):1405-1414.

Tanner NT, Gebregziabher M, Hughes Halbert C, Payne E, Egede LE, Silvestri GA. Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation. Am J Respir Crit Care Med. 2015;192(2):200-208.

Taylor KL, Hagerman CJ, Luta G, et al. Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting: A randomized clinical trial. Lung Cancer. 2017;108:242-246.

The Ottawa Hospital Research Institute. Patient Decision Aids. 2015; https://decisionaid.ohri.ca/training.html.

The Permanente Medical Group. Screening Options for Lung Cancer Emmi. https://mydoctor.kaiserpermanente.org/ncal/mdo/presentation/common/healthToolPage.jsp?path=healthtool_986681.xml.

Townsend CO, Clark MM, Jett JR, et al. Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer. 2005;103(10):2154-2162.

Tsai E, Chiles C, Carter B, et al. Incidental Findings on Lung Cancer Screening: Significance and Management. Seminars in Ultrasound, CT, and MRI. In press.

U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General,. In. Atlanta, GA 2014.

Force USPST. Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2009;150(8):551-555.

Wender R, Fontham ET, Barrera E, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013;63(2):107-117.

Wiener RS, Gould MK, Arenberg DA, et al. An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. Am J Respir Crit Care Med. 2015;192(7):881- 891.

Wiener RS, Slatore CG, Gillespie C, Clark JA. Pulmonologists’ Reported Use of Guidelines and Shared Decision-making in Evaluation of Pulmonary Nodules: A Qualitative Study. Chest. 2015;148(6):1415-1421.

References

  1. American Academy of Family Physicians. Clinical Preventive Service Recommendation – Lung Cancer Screening. 2013; https://www.aafp.org/patient-care/clinical-recommendations/all/lung-cancer.html.
  2. Jaklitsch MT, Jacobson FL, Austin JH, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg. 2012;144(1):33-38.
  3. Wender R, Fontham ET, Barrera E, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013;63(2):107-117.
  4. Ma5one P. Lung Cancer Screening Guidelines. Paper presented at: American College of Chest Physicians 20172017; Toronto, ON.
  5. American Lung Association. Is lung cancer screening right for me? 2017; http://www.lung.org/assets/documents/lung-cancer/interactive-library/lung-cancer-screening-is-it.pdf.
  6. Wiener RS, Gould MK, Arenberg DA, et al. An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. Am J Respir Crit Care Med. 2015;192(7):881- 891.
  7. National Comprehensive Cancer Network. Lung Cancer Screening. Version 1.2017. In:2017.
  8. Moyer VA, Force USPST. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(5):330-338.
  9. Department of Health and Human Services. Center for Medicare & Medicaid Services. Decision Memo for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) (CAG- 00439N). 2015; https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=274.
  10. Fintelmann FJ, Bernheim A, Digumarthy SR, et al. The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program. Radiographics. 2015;35(7):1893- 1908.
  11. National Academies of Sciences E, and Medicine,. Implementation of Lung Cancer Screening: Proceedings of a Workshop. In. Washington, DC: The National Academies Press; 2017.
  12. Mazzone PJ, Silvestri GA, Patel S, et al. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. Chest. 2018;153(4):954-985.
  13. Mazzone P, Powell CA, Arenberg D, et al. Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest. 2015;147(2):295-303.
  14. International Early Lung Cancer Action Program. I-ELCAP Training Protocols http://www.ielcap. org/sites/default/files/I-ELCAP-protocol.pdf.
  15. International Early Lung Cancer Action Program. Publications. http://www.ielcap.org/publications.
  16. American College of Radiology. Lung-RADS Assessment Categories. 2014; https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Lung-Rads.
  17. American College of Radiology. LCSR Required Data Elements. 2017; https://nrdrsupport.acr.org/support/solutions/articles/11000041252.
  18. Carlson C. Medicare outlines payment rules for CT lung cancer screening. 2016.
  19. CY 2018 OPPS Final Rule Initial Summary [press release]. 2017.
  20. Patz EF, Pinsky P, Gatsonis C, et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. 2014;174(2):269-274.
  21. Department of Health and Human Services. Centers for Medicare and Medicaid Services. CMS Credentialed Video on Lung cancer screening.
  22. Burkholder R, Legare F, Friedberg M, Fournier A. Overcoming Barriers to Shared Decision-Making [webinar] [Internet]: Agency for Healthcare Research and Quality; 2015. Podcast. Available from: https://www.pcpcc.org/event/2015/05/ahrq-national-webinar-overcoming-barriers-shared-decision-making-webinar.
  23. Joseph-Williams N, Elwyn G, Edwards A. Knowledge is not power for patients: a systematic review and thematic synthesis of patient-reported barriers and facilitators to shared decision making. Patient Educ Couns. 2014;94(3):291-309.
  24. Penner LA, Dovidio JF, Gonzalez R, et al. The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions. J Clin Oncol. 2016;34(24):2874-2880.
  25. Gordon HS, Street RL, Sharf BF, Kelly PA, Souchek J. Racial differences in trust and lung cancer patients’ perceptions of physician communication. J Clin Oncol. 2006;24(6):904-909.
  26. Tanner NT, Gebregziabher M, Hughes Halbert C, Payne E, Egede LE, Silvestri GA. Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation. Am J Respir Crit Care Med. 2015;192(2):200-208.
  27. DeSantis C, Naishadham D, Jemal A. Cancer statistics for African Americans, 2013. CA Cancer J Clin. 2013;63(3):151-166.
  28. Gallagher CM, Goovaerts P, Jacquez GM, Hao Y, Jemal A, Meliker JR. Racial disparities in lung cancer mortality in U.S. congressional districts, 1990-2001. Spat Spatiotemporal Epidemiol. 2009;1(1):41-47.
  29. Japuntich SJ. Racial Disparities in Lung Cancer Screening: An Exploratory Investigation. In. Journal of the National Medical Association 2017.
  30. Bissell P, May CR, Noyce PR. From compliance to concordance: barriers to accomplishing a re-framed model of health care interactions. Soc Sci Med. 2004;58(4):851-862.
  31. Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395-409.
  32. Pinsky PF, Gierada DS, Black W, et al. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med. 2015;162(7):485-491.
  33. Department of Health and Human Services. Centers for Medicare & Medicaid Services. Pub 100-04 Medicare Claims Processing. 2015; https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/Downloads/R3374CP.pdf.
  34. Department of Health and Human Services. Centers for Medicare & Medicaid Services. Medicare Coverage of Screening for Lung Cancer with Low Dose Computed Tomography (LDCT). MLN Matters Number: MM9246 Revised. 2017; https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/Downloads/MM9246.pdf.
  35. Carter-Harris L, Gould MK. Multilevel Barriers to the Successful Implementation of Lung Cancer Screening: Why Does It Have to Be So Hard? Ann Am Thorac Soc. 2017;14(8):1261-1265.
  36. Tsai E, Chiles C, Carter B, et al. Incidental Findings on Lung Cancer Screening: Significance and Management. Seminars in Ultrasound, CT, and MRI. In press.
  37. Shemesh J. Coronary artery calcification in clinical practice: what we have learned and why should it routinely be reported on chest CT? Ann Transl Med. 2016;4(8):159.
  38. U.S. Preventive Services Task Force. Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2009;150(8):551-555.
  39. Townsend CO, Clark MM, Jett JR, et al. Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer. 2005;103(10):2154-2162.
  40. Tammemägi MC, Berg CD, Riley TL, Cunningham CR, Taylor KL. Impact of lung cancer screening results on smoking cessation. J Natl Cancer Inst. 2014;106(6):dju084.
  41. Borondy Kitts AK, McKee AB, Regis SM, Wald C, Flacke S, McKee BJ. Smoking cessation results in a clinical lung cancer screening program. J Thorac Dis. 2016;8(Suppl 6):S481-487.
  42. Taylor KL, Hagerman CJ, Luta G, et al. Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting: A randomized clinical trial. Lung Cancer. 2017;108:242-246.
  43. U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General,. In: Prevention CfDCa, ed. Atlanta, GA2014.
  44. Siana JE, Rex S, Gottrup F. The effect of cigarette smoking on wound healing. Scand J Plast Reconstr Surg Hand Surg. 1989;23(3):207-209.
  45. Haskins IN, Amdur R, Vaziri K. The effect of smoking on bariatric surgical outcomes. Surg Endosc. 2014;28(11):3074-3080.
  46. Abu Hassan H, Abd Aziz N, Hassan Y, Hassan F. Does the duration of smoking cessation have an impact on hospital admission and health-related quality of life amongst COPD patients? Int J Chron Obstruct Pulmon Dis. 2014;9:493-498.
  47. Sekine Y, Katsura H, Koh E, Hiroshima K, Fujisawa T. Early detection of COPD is important for lung cancer surveillance. Eur Respir J. 2012;39(5):1230-1240.
  48. Løkke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006;61(11):935-939.
  49. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225-249.
  50. NLST Smoking Status Questionnaire. ACRIN SS 6654. https://www.acrin.org/Portals/0/Protocols/6654/forms/6654ss.pdf.
  51. Department of Health and Human Services. Centers for Medicare & Medicaid Services. Eligible Professional Meaningful Use Core Measures. Measure 9 of 13. 2014; https://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/downloads/9_Record_Smoking_Status.pdf.
  52. Abbot NC, Stead LF, White AR, Barnes J, Ernst E. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev. 2000(2):CD001008.
  53. Anderson JE, Jorenby DE, Scott WJ, Fiore MC. Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation. Chest. 2002;121(3):932-941.
  54. Leone FT, Evers-Casey S, Toll BA, Vachani A. Treatment of tobacco use in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e61S-e77S.
  55. American Cancer Society. Cancer Facts & Figures 2014. In. Atlanta: American Cancer Society; 2014.

Back To Top